Vidcast: https://www.instagram.com/reel/DHDz1lkRXs9/

The vaccine against the human papilloma virus, Gardasil, was first recommended for teens and those younger than 45 in 2006. Since then, this vaccine has been instrumental in cutting the incidence of cervical pre-cancerous lesions by 80% according to a just-published CDC analysis.

Since the vaccine’s introduction, vaccination rates have steadily increased resulting in that dramatic 80% decline in the most dangerous pre-cancerous cervical lesions, so-called carcinoma-in-situ or CIS.

This data confirms the effectiveness of Gardasil to curb the tide of the devastating cervical cancer. Though vaccination rates have risen, the latest data shows that only 61% of teens 13-15 years have received the vaccine. Since sexually-active teens can spread the infection, Gardasil is also recommended for teen boys but only 57% of them have been vaccinated.

This lifesaving vaccine should be universally adopted. All teens should receive a 3 shot Gardasil course at 13 years or earlier.

https://www.cdc.gov/mmwr/volumes/74/wr/mm7406a4.htm

https://progressreport.cancer.gov/prevention/hpv_immunization

#cervical #cancer #precancerous #carcinomainsitu #vaccine #gardasil

Success: Vaccine Prevention of Cervical Cancer

Dr. Howard Smith Reports